LICHENSTEIN, HENRI,JEFFERS, MIKE,QIAN, XIAOZHANG,SEHESTED, MAXWELL,PETERSEN, KAMILLE DUMONG,RITCHIE, JAMES
申请号：
CA2596210
公开号：
CA2596210C
申请日:
2006.02.03
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
The present invention pertains to a method for treating cancer, such as lungcancer, multiple myeloma, lymphoma,and epithelial ovarian cancer, comprising the administration to a patient inneed thereof a first amount or dose of a histone deacetylase(HDAC) inhibitor, such as PXD-101, and a second amount or dose of anotherchemotherapeutic agent, such as dexamethasone or5-fluorouracil, or an epidermal growth factor receptor (EGER) inhibitor, suchas TarcevaU, wherein the first and second amounts ordoses together comprise a therapeutically effective amount.
